# EDGAR Filing Document

**Accession Number:** 0001742555
**File Stem:** 0001415889-23-004187
**Filing Date:** 2023-3
**Character Count:** 7091
**Document Hash:** 234150f8aeff7daa902fd5dc5cf32079
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001415889-23-004187.hdr.sgml**: 20230303

**ACCESSION NUMBER**: 0001415889-23-004187

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230302

**FILED AS OF DATE**: 20230303

**DATE AS OF CHANGE**: 20230303

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Parra Raul Jr.
- **CENTRAL INDEX KEY:** 0001742555

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-18592
- **FILM NUMBER:** 23706315

**MAIL ADDRESS:**
- **STREET 1:** 1600 WEST MERIT PARKWAY
- **CITY:** SOUTH JORDAN
- **STATE:** UT
- **ZIP:** 84095
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MERIT MEDICAL SYSTEMS INC
- **CENTRAL INDEX KEY:** 0000856982
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **IRS NUMBER:** 870447695
- **STATE OF INCORPORATION:** UT
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 1600 WEST MERIT PARK WAY
- **CITY:** SOUTH JORDAN
- **STATE:** UT
- **ZIP:** 84095
- **BUSINESS PHONE:** 8012531600

**MAIL ADDRESS:**
- **STREET 1:** 1600 WEST MERIT PARKWAY
- **CITY:** SOUTH JORDAN
- **STATE:** UT
- **ZIP:** 84095

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Parra Raul Jr.<br><sub>(Last) (First) (Middle)</sub><br>1600 WEST MERIT PARKWAY<br><sub>(Street)</sub><br>SOUTH JORDAN, UT 84095<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-03-02 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_CFO AND TREASURER_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>MERIT MEDICAL SYSTEMS INC [ MMSI ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock, No Par Value | 2023-03-02 |  | M |  | 6000 | A | $37.71 | 19697 | D |  |
| Common Stock, No Par Value | 2023-03-02 |  | S |  | 11986 | D | $70 | 7711 | D |  |
| Common Stock, No Par Value |  |  |  |  |  |  |  | 2872 | I | By 401(k) Plan<sup>(1)</sup> |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Non-qualified stock options (right to buy) | $37.71 | 2023-03-02 |  | M |  |  | 6000 | 2021-02-26<sup>(2)</sup> | 2027-02-26 | Common Stock | 6000 | $0 | 10722 | D |  |
| Non-qualified stock options (right to buy) | $44.80 |  |  |  |  |  |  | 2019-03-02<sup>(3)</sup> | 2025-03-02 | Common Stock | 4000 |  | 4000 | D |  |
| Non-qualified stock options (right to buy) | $55.73 |  |  |  |  |  |  | 2020-03-01<sup>(4)</sup> | 2026-03-01 | Common Stock | 30000 |  | 30000 | D |  |
| Non-qualified stock options (right to buy) | $56.25 |  |  |  |  |  |  | 2022-03-19<sup>(5)</sup> | 2028-03-19 | Common Stock | 9681 |  | 9681 | D |  |
| Non-qualified stock options (right to buy) | $70.58 |  |  |  |  |  |  | 2024-02-28<sup>(6)</sup> | 2030-02-28 | Common Stock | 13576 |  | 13576 | D |  |
| Non-qualified stock options (right to buy) | $65.03 |  |  |  |  |  |  | 2023-02-28<sup>(7)</sup> | 2029-02-28 | Common Stock | 14570 |  | 14570 | D |  |

---

### Footnotes:

(1) Represents plan holdings as of 01/31/2023.

(2) Becomes exercisable in equal annual installments of 25% commencing 02/26/2021.

(3) Becomes exercisable in equal annual installments of 20% commencing 03/02/2019.

(4) Becomes exercisable in equal annual installments of 20% commencing 03/01/2020.

(5) Becomes exercisable in equal annual installments of 25% commencing 03/19/2022.

(6) Becomes exercisable in equal annual installments of 25% commencing 02/28/2024.

(7) Becomes exercisable in equal annual installments of 25% commencing 02/28/2023.

**Signature:** /s/ Brian G. Lloyd, Attorney-in-Fact  
**Date:** 2023-03-03

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**